Axsome's (AXSM-0.50%) revenue is soaring thanks to strong momentum for two drugs -- Auvelity and Sunosi. The company launched Auvelity in October 2022 as a treatment for major depressive disorder. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results